SEC Form 4 · accession 0001144204-17-055543
CALADRIUS BIOSCIENCES, INC. · CLBS
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Douglas W Losordo
Officer — See Remarks
Period of report
Nov 1, 2017
Accepted (ET)
Nov 1, 2017 · 5:07 pm EDT
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0000320017
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common StockF1 | Nov 1, 2017 | A | 49,182 | $0.00 | A | 68,876 | D |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1The shares are restricted. The restricted shares fully vest in three equal installments on the date of grant and on the first and second anniversaries of the date of grant.
Remarks
Senior Vice President, Clinical, Medical and Regulatory Affairs and Chief Medical Officer